Shaw A.T.Solomon B.J.Besse B.Bauer T.M.CHIA-CHI LINSoo R.A.Riely G.J.Ignatius Ou S.-H.Clancy J.S.Li S.Abbattista A.Thurm H.Satouchi M.Camidge D.R.Kao S.Chiari R.Gadgeel S.M.Felip E.Martini J.-F.2022-09-152022-09-1520190732-183Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85065811977&doi=10.1200%2fJCO.18.02236&partnerID=40&md5=2678ac2b2f97ac69302ce06fb7ccb946https://scholars.lib.ntu.edu.tw/handle/123456789/620261[SDGs]SDG3ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non–small-cell lung cancerjournal article10.1200/JCO.18.02236308929892-s2.0-85065811977